ConductScience.org, home

Paper36967432

The predictive value of the modified AFP model for liver transplantation outcomes in multinodular hepatocellular carcinoma patients.

Wang J and 13 others. World J Surg Oncol, 2023. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. The predictive value of the modified AFP model for liver transplantation outcomes in multinodular hepatocellular carcinoma patients. Papers, record 36967432. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36967432

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The predictive value of the modified AFP model for liver transplantation outcomes in multinodular hepatocellular carcinoma patients.
PubMed
Journal
World J Surg Oncol
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.3
iCite
Revised in PubMed
2023-03-29
PubMed

Authors14

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wang JJingrui
2Bao JJiaqi
3Wang RRui
4Hong JJiachen
5Zhang LLincheng
6Que QQingyang
7Xu SShengjun
8Wu YYongfeng
9Zhan QQifan
10Liu YYuchen
11Liu JJimin
12Zheng SShusen
13Ling SSunbin
14Xu XXiao

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, HepatocellularMajor topic
Liver NeoplasmsMajor topic
Liver TransplantationMajor topic
Humans
alpha-Fetoproteins
Neoplasm Recurrence, Local
Retrospective Studies
Risk Factors

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
82273270National Natural Science Foundation of ChinaPubMed
92159202National Natural Science Foundation of ChinaPubMed

Source PubMed

Download CSV of grants

References18

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128989060Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma.Gastroenterology2018https://conductscience.org/library/papers/28989060PubMed
233433946Cancer Statistics, 2021.CA Cancer J Clin2021https://conductscience.org/library/papers/33433946PubMed
311460231Influence of tumor characteristics on the outcome of liver transplantation among patients with liver cirrhosis and hepatocellular carcinoma.Liver Transpl2001https://conductscience.org/library/papers/11460231PubMed
48594428Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.N Engl J Med1996https://conductscience.org/library/papers/8594428PubMed
527899297Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC.J Hepatol2017https://conductscience.org/library/papers/27899297PubMed
632201284Including mRECIST in the Metroticket 2.0 criteria improves prediction of hepatocellular carcinoma-related death after liver transplant.J Hepatol2020https://conductscience.org/library/papers/32201284PubMed
727169841Liver transplantation for hepatocellular carcinoma: evaluation of the alpha-fetoprotein model in a multicenter cohort from Latin America.Liver Int2016https://conductscience.org/library/papers/27169841PubMed
817563735Competing risk analysis using R: an easy guide for clinicians.Bone Marrow Transplant2007https://conductscience.org/library/papers/17563735PubMed
928295992Liver transplantation versus liver resection for hepatocellular carcinoma in intention to treat: An attempt to perform an ideal meta-analysis.Liver Transpl2017https://conductscience.org/library/papers/28295992PubMed
1020062101Regression modeling of competing risk using R: an in depth guide for clinicians.Bone Marrow Transplant2010https://conductscience.org/library/papers/20062101PubMed
1133021344Recent developments and ongoing trials in transplant oncology.Liver Int2020https://conductscience.org/library/papers/33021344PubMed
1211391528Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival.Hepatology2001https://conductscience.org/library/papers/11391528PubMed
1325804634Liver transplantation for hepatocellular carcinoma beyond the Milan criteria.Gut2016https://conductscience.org/library/papers/25804634PubMed
1429307467Hepatocellular carcinoma.Lancet2018https://conductscience.org/library/papers/29307467PubMed
1522750200Liver transplantation for hepatocellular carcinoma: a model including α-fetoprotein improves the performance of Milan criteria.Gastroenterology2012https://conductscience.org/library/papers/22750200PubMed
1633031259Management and survival for patients with stage-I hepatocellular carcinoma: An observational study based on SEER database.Medicine (Baltimore)2020https://conductscience.org/library/papers/33031259PubMed
1719058754Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis.Lancet Oncol2009https://conductscience.org/library/papers/19058754PubMed
1825777590Total tumor volume and alpha-fetoprotein for selection of transplant candidates with hepatocellular carcinoma: A prospective validation.Hepatology2015https://conductscience.org/library/papers/25777590PubMed

Download CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42008358SREBP2 as a Novel Biomarker for Posttransplant Hepatocellular Carcinoma Recurrence: A New Prognostic Nomogram.Biomed Res Int2026https://conductscience.org/library/papers/42008358PubMed
40709064Liver transplantation for HCC within and beyond Milan Criteria: single center experience with literature review.Front Surg2025https://conductscience.org/library/papers/40709064PubMed
40355422Multi-omic analysis reveals a CAF-stemness-governed classification in HCC liver transplant recipients beyond the Milan criteria.Nat Commun2025https://conductscience.org/library/papers/40355422PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
AFP174PubTator's text mininghttps://conductscience.org/library/genes/174

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36967432

GET https://conductscience.org/api/papers/v1/36967432/authors